Screener
Bio-Techne TECH Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | March 31, 2026 / (unaudited) | June 30, 2025 |
|---|---|---|
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Trade accounts payable | $23,490 | $25,311 |
| Salaries, wages and related accruals | 54,429 | 65,791 |
| Accrued expenses | 17,682 | 25,663 |
| Contract liabilities | 38,433 | 32,571 |
| Income taxes payable | 2,971 | 10,770 |
| Operating lease liabilities - current | 14,181 | 14,098 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's accrued expenses?
- Bio-Techne (TECH) reported accrued expenses of $54.43M in Q1 2026.
- How has Bio-Techne's accrued expenses changed year-over-year?
- Bio-Techne's accrued expenses decreased by 12.1% year-over-year, from $61.9M to $54.43M.
- What is the long-term trend for Bio-Techne's accrued expenses?
- Over 4 years (2021 to 2025), Bio-Techne's accrued expenses has grown at a 6.4% compound annual growth rate (CAGR), from $51.29M to $65.79M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Bio-Techne's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude